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Staphylococcus aureus causesmany diseases in humans, ranging frommild skin infections
to serious, life-threatening, superantigen-mediatedToxic Shock Syndrome (TSS). S. aureus
may be asymptomatically carried in the anterior nares or vagina or on the skin, serving as
a reservoir for infection. Pulsed-ﬁeld gel electrophoresis clonal type USA200 is the most
widely disseminated colonizer and the leading cause of TSS. The cytolysin α-toxin (also
known as α-hemolysin or Hla) is the major epithelial proinﬂammatory exotoxin produced
by TSS S. aureus USA200 isolates. The current study aims to characterize the differences
betweenTSS USA200 strains [high (hla+) and low (hla−) α-toxin producers] in their ability to
disrupt vaginal mucosal tissue and to characterize the subsequent infection.Tissue viability
post-infection and bioﬁlm formation ofTSS USA200 isolates CDC587 and MN8, which con-
tain the α-toxin pseudogene (hla−), MNPE (hla+), andMNPE isogenic hla knockout (hlaKO),
were observed via LIVE/DEAD® staining and confocal microscopy. All TSS strains grew to
similar bacterial densities (1–5× 108 CFU) on the mucosa and were proinﬂammatory over
3 days. However, MNPE formed bioﬁlms with signiﬁcant reductions in the mucosal viabil-
ity whereas neither CDC587 (hla−), MN8 (hla−), nor MNPE hlaKO formed bioﬁlms. The
latter strains were also less cytotoxic than wild-type MNPE. The addition of exogenous,
puriﬁed α-toxin to MNPE hlaKO restored the bioﬁlm phenotype.We speculate that α-toxin
affects S. aureus phenotypic growth on vaginal mucosa by promoting tissue disruption
and bioﬁlm formation. Further, α-toxin mutants (hla−) are not benign colonizers, but rather
form a different type of infection, which we have termed high density pathogenic variants
(HDPV).
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INTRODUCTION
Bioﬁlms are a community of micro-organisms that are embedded
in an extracellular matrix (ECM) composed of lipids, proteins,
polysaccharides, and DNA. They are formed in a multi-stage
process which includes initial attachment, accumulation, matu-
ration, and dispersion (Gotz, 2002; Hall-Stoodley et al., 2004;
Latasa et al., 2006; Heilmann, 2011). The members of a bioﬁlm
are protected from environmental factors such as ultraviolet light
and dehydration, as well as from host immune factors such as
neutrophils andmacrophages (Hall-Stoodley et al., 2004). Bioﬁlm-
associated bacteria are also much more resistant to antibiotics and
antimicrobial agents (Mah and O’Toole, 2001; Stewart and Coster-
ton, 2001). This resistance is on the order of 100- to 1000-fold
higher than the planktonic form and can be attributed to genetic
factors, growth rate, metabolic factors, and the physical properties
of the bioﬁlm ECM (Gilbert et al., 2002).
Recently, there has been a great deal of interest in the role of
bioﬁlms in infectious diseases. The National Institutes of Health
has estimated that ∼80% of human infections are caused by
pathogenic bioﬁlms (bioﬁlms). Bioﬁlm-mediated infections affect
wounds, blood,mucosal surfaces (sinuses, respiratory, and genito-
urinary tracts), and medical devices (endotracheal tubes, intravas-
cular and urinary catheters, orthopedic implants, and arterial
stents; Towne et al., 1994; Donlan, 2001; Bakaletz, 2007; Wolcott
et al., 2008; Rohrich et al., 2010). Device-related bioﬁlm infections
were the ﬁrst to be described in the 1980s (Marrie et al., 1982).
Staphylococcus epidermidis and Staphylococcus aureus are the most
frequent causes of medically associated bioﬁlms (Arciola et al.,
2001; Lentino, 2003).
Staphylococcus aureus is an opportunistic pathogen which
causes a wide variety of diseases in humans, ranging from rela-
tively mild skin and soft tissue infections to severe, life-threatening
necrotizing pneumonia, bacteremia, and Toxic Shock Syndrome
(TSS; Lowy, 1998). This organism is the most common cause
of ventilator-associated pneumonia, surgical site infections, and
catheter-associated bloodstream infections in the healthcare set-
ting (Kuehnert et al., 2005). S. aureus is also a common cause of
skin and pulmonary infections in the community (Zetola et al.,
2005). Infections caused by S. aureus are often preceded by colo-
nization. In fact, carriers have a threefold higher risk for S. aureus
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Table 1 | Staphylococcus aureus strains used in this study.
Strain ID Clonal type α-Toxin genotype Characteristic Reference
MNPE USA200 hla+ Wild-type α-toxin, post-inﬂuenzaTSS lung isolate MacDonald et al. (1987)
CDC587 USA200 hla− α-Toxin pseudogene, mTSS isolate Schlievert et al. (1982)
MN8 USA200 hla− α-Toxin pseudogene, mTSS isolate Schlievert et al. (1982)
MNPE hlaKO USA200 hla deﬁcient MNPE with α-toxin deletion (hla::erm), isogenic strain Lin et al. (2011)
infections (Wertheim et al., 2005). S. aureus is carried asympto-
matically in the anterior nares, skin, and vaginal mucosa by up to
30% of the population (Kuehnert et al., 2006; Gorwitz et al., 2008).
USA200 methicillin-susceptible S. aureus (MSSA) are the most
common pulsed-ﬁeld gel electrophoresis (PFGE) type isolated
from the nose and are a frequent cause of healthcare associated
infections (Patel et al., 2008; Tenover et al., 2008). USA200 MSSA
are also a major cause of TSS, as they are often associated with
expression of the TSS toxin-1 gene (tst ; Peacock et al., 2002; Diep
et al., 2006; Tenover et al., 2008).
Staphylococcus aureus illnesses are usually initiated at mucosal
surfaces or skin. Bacteremia is not typically associated with men-
strual TSS; however, toxin penetration across the mucosa can be
facilitated by the activity of other exotoxins, including the cyto-
toxin,α-toxin (Peterson et al., 2005; Brosnahan et al., 2009), which
is an exotoxin known to play a role in the pathogenesis of S. aureus
(Patel et al., 1987; Bramley et al., 1989). This cytotoxin is secreted
as a water soluble monomer which forms a heptameric β-barrel
pore in host cellmembranes (Song et al., 1996). Targets of the toxin
include lymphocytes,macrophages, epithelium, endothelium, and
erythrocytes (Bhakdi and Tranum-Jensen, 1991).
Recently, the exoprotein proﬁles of two USA200 TSS S. aureus
isolates, MNPE (α-toxin positive, hla+) and CDC587 (α-toxin
mutant, hla−) were biochemically characterized (Lin et al., 2011).
The MNPE strain is a pulmonary post-inﬂuenza TSS isolate,
whereas CDC587 is a menstrual, vaginal TSS isolate which con-
tains a pseudogene for α-toxin (Schlievert et al., 1982; MacDonald
et al., 1987). The exoproteins from MNPE were signiﬁcantly more
proinﬂammatory and cytotoxic, in vitro, to immortalized human
vaginal epithelial cells (HVECs) than those from the vaginal isolate
CDC587 (Lin et al., 2011). This was due to the presence of large
amounts of α-toxin in supernatants from MNPE.
An ex vivo porcine vaginal mucosa infection model was used to
further characterize the differences between TSS USA200 S. aureus
hla+ and low α-toxin-producing hla− strains with regard to their
abilities to infect anddisrupt vaginalmucosal tissue.All TSS strains
grow to similar bacterial densities on the vaginal mucosa. MNPE
(hla+) proved to be highly cytotoxic to the vaginal epithelium as
early as 24 h post-infection. Cytotoxic effects of CDC587 (hla−)
andMN8 (hla−) aremuch lower anddonot appear until 48 hpost-
infection. Of particular interest, MNPE forms mature bioﬁlms by
72 h post-infection, whereas CDC587, MN8, and MNPE hlaKO
isolates infect the tissue but do not form bioﬁlms. Further, exoge-
nous α-toxin restores the mature bioﬁlm phenotype of the MNPE
hlaKO strain. These data suggest that α-toxin contributes to TSS
S. aureus mucosal bioﬁlm formation while causing signiﬁcant dis-
ruption to themucosa.Additionally, the absence of α-toxin did not
inhibit TSS S. aureus isolates from infecting the vaginal mucosa,
but growth occurred with a different, non-bioﬁlm phenotype. As
these non-bioﬁlm-forming strains grow to a high density on the
tissue and are proinﬂammatory,we have termed themhigh density
pathogenic variants (HDPV).
MATERIALS AND METHODS
BACTERIA
USA200 isolates MNPE, CDC587, and MN8 were used extensively
in this study (Table 1). All three strains are methicillin sensitive
S. aureus (MSSA). MNPE was isolated from a post-inﬂuenza pul-
monary TSS case in 1987 and most likely originated from a skin
source (MacDonald et al., 1987). CDC587 and MN8 are typical
menstrual vaginal TSS strains, isolated from patients in the 1980s
(Schlievert et al., 1982). Previously described isogenicα-toxindele-
tion mutants, MNPE hlaKO, CDC587 hlaKO, were used in some
studies (Lin et al., 2011). All bacteria are maintained in the labo-
ratory as frozen glycerol stocks. Prior to experimentation, Tryptic
Soy Agar containing 5% sheep’s blood (TSB, Becton–Dickinson,
Franklin Lakes, NJ, USA) is inoculated from frozen stocks. On the
afternoon prior to initiation of experiment, Todd Hewitt broth
(Becton–Dickinson) is inoculated with colonies from the fresh
TSB plates. Stationary phase (overnight) cultures of each strain are
washed in RMPI 1640 (Invitrogen, Carlsbad, CA, USA) and resus-
pended to a concentration of approximately 5× 108 colony form-
ing units (CFU/ml). Two microliters of this suspension are used to
inoculate explants on themucosal surface (1× 106 CFU/explants).
Explants are returned to 37˚C and incubated for up to 4 days. All
studies are performed in a biosafety level 2 (BSL2) laboratory.
EX VIVO PORCINE VAGINAL MUCOSA PREPARATION AND INFECTION
Porcine vaginal mucosa has been reported to be histologically
and structurally similar to human vaginal mucosa (Squier et al.,
2008). Therefore, we developed an ex vivo porcine vaginal mucosa
infection model to characterize the role of α-toxin in S. aureus
mucosal bioﬁlm formation. Normal healthy porcine vaginal tis-
sue is excised from animals at slaughter and transported to the
laboratory in RPMI 1640 media supplemented with 10% fetal
calf serum, penicillin (50 IU/ml), streptomycin (50mg/ml), and
amphotericinB (2.5μg/ml).Antibiotics are included todecolonize
vaginal normal ﬂora which may interfere with bioﬁlm forma-
tion (Iwase et al., 2010). Tissue is utilized within 3 h of excision.
Explants of uniform size are obtained from the porcine vagina
using a 5-mm biopsy punch. Excess muscle tissue is trimmed away
with a scalpel. Tissue explants are washed in antibiotic-free RPMI
1640 media three times. The explants are then placed mucosal
side up on a PET track-etched 0.4μm cell culture insert (BD Bio-
science, Franklin Lakes, NJ, USA) in 6-well plates containing fresh
serum- and antibiotic-free RPMI 1640 and incubated at 37˚C. The
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mucosal surface is continually exposed to air. The mucosal surface
of each is inoculated with ∼1× 106 CFU of bacteria suspended
in antibiotic-free RPMI 1640. Infected explants are incubated at
37˚C with 7% CO2. At various times post-infection, samples are
removed from the incubator and processed for bacterial recov-
ery and IL-8 and α-toxin analysis. Some samples were stained
and imaged by confocal laser scanning microscopy (CLSM) after
removal from the incubator.
BACTERIAL BIOFILM AND MUCOSAL VIABILITY DETERMINATIONS
The physical properties of the LIVE/DEAD® staining kit from
Invitrogen and CLSM are utilized to simultaneously deter-
mine microbial bioﬁlm formation and corresponding toxicity to
mucosal tissue. The FilmTracer™LIVE/DEAD® Bioﬁlm Viabil-
ity kit provides a two-color ﬂuorescence assay of bacterial and
mucosal viability based on membrane integrity. This kit utilizes
mixtures of SYTO® 9 green ﬂuorescent nucleic acid stain and
the red-ﬂuorescent nucleic acid stain, propidium iodide. These
stains differ both in their spectral characteristics and in their abil-
ity to penetrate healthy cells. When used alone, the SYTO® 9
stain generally labels all mucosal epithelial cells and/or bacteria
in a population – those with intact membranes and those with
damaged membranes. In contrast, propidium iodide penetrates
only mucosal cells or bacteria with damaged membranes, caus-
ing a reduction in the SYTO® 9 stain ﬂuorescence when both
dyes are present. Thus, with the mixture of the SYTO® 9 and
propidium iodide stains, mucosal cells or bacteria with intact cell
membranes stain ﬂuorescent green,while bacteria or mucosal cells
with damaged membranes stain ﬂuorescent red.
BACTERIAL RECOVERY FROM PORCINE VAGINAL EXPLANTS
Bacteria are enumerated from unwashed, infected explants by vor-
tex mixing (highest setting for 2min or medium high for 4min)
in 250μl sterile phosphate buffered saline (Sigma, St. Louis, MO,
USA). Supernatants are then serially diluted in PBS (or plated
neat) and spread on Tryptic Soy Agar containing 5% sheep’s blood
(Becton Dickinson, Franklin Lakes, NJ, USA) using a spiral plater
(Biotek, Microbiology International, MD, USA).
QUANTIFICATION OF VAGINAL MUCOSA IL-8
Interleukin-8 (IL-8) is a cytokine which is used as an indica-
tor of inﬂammation or irritation. The amount of IL-8 produced
in the vaginal mucosal explants is determined by homogeniz-
ing the explants in 250μl sterile phosphate buffered saline. The
homogenate is clariﬁed by centrifugation and stored at −20˚C
until assayed. We use a porcine speciﬁc IL-8 ELISA (R&D Systems,
Minneapolis, MN, USA) to quantify the amount of IL-8 present
in each explant.
ALPHA-TOXIN DETECTION BY WESTERN IMMUNOBLOTTING
Clariﬁed homogenates are concentrated by ethanol precipitation
(ﬁve-fold) and resuspended in sterile water. Samples are mixed
1:1 with sample loading buffer and electrophoresed on a 4–20%
gradient acrylamide gel (BioRad,Hercules,CA,USA)under reduc-
ing conditions, transferred onto polyvinylidene ﬂuoride (PVDF)
membranes (BioRad, Hercules, CA, USA) and immunoblot-
ted with rabbit α-toxin anti-sera (obtained as described in Lin
et al., 2011). Proteins are detected by chemiluminescence using
SuperSignal West Dura Extended Duration substrate (Pierce,
Rockford, IL, USA).
STAINING AND EXAMINATION BY CLSM
Infected and control explants are stained using FilmTrac-
er™LIVE/DEAD® Bioﬁlm Viability kit (Invitrogen, Carlsbad, CA,
USA) according to manufacturer’s instructions. After staining,
specimens are gently washed three times in Hank’s balanced salt
solution (Invitrogen, Carlsbad, CA, USA) and transferred to glass
slides. A coverslip with 1mm spacer (Electron Microscopy Sci-
ences,Hatﬁeld,PA,USA) is then applied and specimens are imaged
on an Olympus FluoView 1000 BX2 or Zeiss Axio Scope II. Images
are captured using either FluoView or LaserSharp software and
processed using either FluoView or ImageJ software. All images
are 60× original magniﬁcation.
PURIFICATION OF α-TOXIN
The cytolysin α-toxin is puriﬁed as previously described (Brosna-
han et al., 2009). Brieﬂy, α-toxin is isolated from S. aureus strain
MNJA grown in beef heart medium. The culture is precipitated
with ethanol at 4˚C. The precipitate is resolubilized in water, and
α-toxin is puriﬁed by isoelectric focusing (IEF). IEF is conducted
in two phases: the ﬁrst phase uses a pH gradient of 3.5–10, fol-
lowed by a second phase using a pH gradient from 7 to 9. The
isoelectric point of α-toxin is 8.5. Purity is conﬁrmed by SDS-
PAGE and quantiﬁed using the Bio-Rad protein assay (Bio-Rad,
Hercules, CA, USA).
ALPHA-TOXIN TREATMENT
In some experiments, exogenous α-toxin is added to explants
before or after infection with MNPE hlaKO. As a pre-treatment,
puriﬁed α-toxin (5μg/explant) is added and explants are incu-
bated for 6 h at 37˚C. Explants are then infectedwithMNPE hlaKO
and further incubated for 3 day. Alternatively, explants are infected
with MNPE hlaKO and incubated at 37˚C for 24 h, then 5μg of
puriﬁed α-toxin is added and explants are further incubated for
two more days. Following incubation, explants are stained and
imaged as described above.
BIOFILM FORMATION ON PLASTIC
The role of α-toxin in bioﬁlm formation on plastic is evaluated
using two different kinds of 96-well tissue culture plates (TDD
92096, MidSci, St. Louis, MO, USA and Corning 3595, Fisher Sci-
entiﬁc, Pittsburgh, PA,USA) according to the procedure described
previously (Christensen et al., 1985). Brieﬂy, overnight cultures of
S. aureus are diluted 1:20 in Tryptic Soy Broth (BD Bacto, Sparks,
MD,USA) supplementedwith 0.2%sterile glucose (SigmaAldrich,
St. Louis, MO, USA). Ninety-six well plates are inoculated with
200μl of diluted bacteria and allowed to incubate for 24 or 72 h
at 37˚C; care was taken to prevent shaking during incubation.
Following incubation, wells are aspirated and gently washed with
sterile saline three times. Adherent bacteria are ﬁxed overnight at
room temperature with 200 μl of Bouin’s ﬁxative (Ricca Chem-
icals, Arlington, TX, USA). The ﬁxative is then aspirated and
bacteria are stained for 5min at room temperature with Gentian
Violet (Ricca Chemicals, Arlington, TX, USA). Plates are washed
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under running water. Stain is resolubilized with 30% glacial acetic
acid (Fisher Scientiﬁc, Pittsburgh, PA, USA) and optical density is
read at 570 nm.
STATISTICAL ANALYSIS
The data in Figures 2A,B were analyzed by one-way ANOVA fol-
lowed by Bonferroni’s post-test using GraphPad Prism 5 Software
(GraphPad Software Inc., La Jolla, CA, USA) and are represen-
tative of two experiments (pooled) with n = 3–4 per group, per
experiment. The data in Figure 5 were analyzed by one-way
ANOVA followed by Bonferroni’s post-test using GraphPad Prism
5 software. The results are representative of one experiment with
n = 5–8 per strain.
RESULTS
hla+ AND hla− CARRYING STRAINS PRODUCE DIFFERENT INFECTION
PHENOTYPES ON PORCINE VAGINAL MUCOSA
Previous results indicated that secreted exotoxins from MNPE
were highly proinﬂammatory and cytotoxic to immortalized
HVECs when compared to secreted exotoxins from a mTSS
strain, CDC587 (Lin et al., 2011); thus, it was hypothesized
that an α-toxinhigh strain of S. aureus (MNPE, hla+) would
be more cytotoxic to full thickness porcine vaginal mucosal
epithelium compared to hla− carrying menstrual TSS isolates. To
test this hypothesis, a LIVE/DEAD® staining kit from Invitrogen
(green= live cells, red= dead cells) and CLSM were employed.
Throughout the course of the experiment (up to 72 h), unin-
fected mucosal tissue remains alive and intact as demonstrated
by a predominance of green color (Figures 1A,E,I). In contrast,
at 24 h post-infection with MNPE, all of the epithelial cells are
stained red and rounded, demonstrating disrupted membranes
and loss of cell-to-cell adhesion (Figure 1B). The mucosal epithe-
lium of explants infected with hla− strains (either CDC587 or
MN8) remains highly viable (green staining) at 24 h post-infection
(Figures 1C,D), although there is evidence of some cell rounding
inCDC587-infected explants (Figure 1C), suggesting a loss of cell-
to-cell adhesion. At the 48-h timepoint, there is still signiﬁcant
red staining in MNPE-infected explants (Figure 1F). Cytotoxi-
city and cell rounding are evident in CDC587-infected explants
at 48 h post-infection (Figure 1G). The epithelium of explants
infected with MN8 also shows signs of disruption at this inter-
mediate time point, although there are still many viable cells and
areas of intact cell junctions (Figure 1H). After 72 h, the only evi-
dence of epithelium in MNPE-infected explants are faint red spots
FIGURE 1 | hla+ and hla−carrying strains produce different infection
phenotypes on porcine vaginal mucosa. Explants of normal, healthy
porcine vaginal mucosa were infected with ∼1×106 CFU of live S. aureus
strains MNPE, CDC587, or MN8. Uninfected or infected porcine vaginal
mucosal epithelium explants were stained with FilmTracer™LIVE/DEAD
stain, then gently washed to remove excess stain. CLSM was used to
image explants at the indicated times post-infection. (A,E,I) Uninfected
tissue remains live (green) and intact (asymmetrical) throughout the
course of the experiment. (B) MNPE-infected tissue is dead (red) by 24 h.
Some bacteria are attached to the tissue (small, green staining). (C,D) In
contrast, the tissue infected with CDC587 or MN8 resembles uninfected
tissue at 24 h. (F) At 48 h, more bacteria are evident in the MNPE-infected
tissue. (G,H) Some of the tissue infected with CDC587 or MN8 has died
(red) and sloughed away (black). Small, individual cocci (small, bright green
punctuate staining) are beginning to appear. (J) At 72 h, MNPE bioﬁlm
(diffuse green) has overtaken the tissue. (K) At 72 h post-infection, most of
the tissue has been killed by CDC587, very few cocci are observed. (L) At
72 h post-infection with MN8 results in ∼50% cell death (red/black areas).
Some macro-colonies are beginning to form in the lower right quadrant.
Original magniﬁcation was 60×.
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in random patterns (Figure 1J, lower right quadrant). In contrast,
bright green live epithelial cells remain (although they are sparse)
in explants infected with CDC587 (Figure 1K). MN8 appears to
be less cytotoxic to the mucosal tissue than either CDC587 or
MNPE, as evidenced by larger areas of bright green stained epithe-
lial cells (Figure 1L). These results indicate that strains-producing
α-toxin are more cytotoxic to the mucosal epithelium than strains
producing low amounts or no α-toxin.
The dyes used for CLSM also allowed imaging of the bacte-
ria growing on the porcine vaginal mucosa over time. At 24 h, in
MNPE-infected explants, some bacteria are observed (small green,
Figure 1B). In contrast, the hla− bacteria are not visualized at this
time point, based on a lack of small bright green punctate stain-
ing in explants (Figures 1C,D). At the intermediate time point
(48 h post-infection), MNPE has entered the accumulation phase
of bioﬁlm development (Figure 1F). Microcolonies are observed
to be interspersed between dead epithelial cells. Both hla− strains
are beginning to be visible on the tissue (small, green, punctate
staining, Figures 1G,H). Further, it appears that at least a por-
tion of the MN8 bacteria are intracellular, as evidenced by the
small, bright green punctate stainingwithin themore diffuse green
staining (Figure 1H). By 72 hpost-infection,bioﬁlmhas overtaken
most of the MNPE-infected explants (large green mass,Figure 1J),
which is in stark contrast to explants infected with strains carry-
ing the hla pseudogene (hla−). Only sparse, individual colonies
are observed in CDC587-infected explants (Figure 1K). S. aureus
growth on MN8-infected explants was intermediate, with micro-
colonies beginning to form by 72 h (Figure 1L). These data suggest
a role for α-toxin in the formation of mucosal bioﬁlms.
S. AUREUS (hla+ AND hla−) GROW TO SIMILAR DENSITIES ON THE
MUCOSAL SURFACE
The CFU recovered from infected, unwashed tissue were enumer-
ated to determine if there were intrinsic differences in the ability
of hla+ or hla− strains to grow on porcine vaginal mucosa. No
signiﬁcant differences across strains were observed in the number
of bacteria recovered from the tissue at any time point examined
(Figure 2A, n = 6, p> 0.05). CFU values across strains were then
pooled and evaluated for an effect of time. There is an increase
in the amount of bacteria recovered from 24 to 48 h. Twenty-four
hours after infection of the tissue with ∼6.0 Log10 CFU/explant,
the bacterial densities are 7.83± 0.07 Log10 CFU/explant. By 48 h,
the bacterial density is signiﬁcantly increased to 8.41± 0.04 Log10
CFU/explant (n = 18, p< 0.0001). No further increase is observed
between 48 and 72 h (8.41± 0.02 Log10 CFU/explants, n = 18,
p = 0.9543). These data demonstrate that all of the strains grew to
a density at which cytolysins would be expressed.
S. AUREUS STRAINS (hla+ OR hla−) ARE PROINFLAMMATORY TO THE
VAGINAL MUCOSA
The cytokine interleukin-8 (IL-8) is chemotactic for neutrophils
and is considered a marker of inﬂammation. A signiﬁcant increase
in the amount of IL-8 produced by vaginal explants at 24 and
48 h post-infection is observed with all strains of S. aureus tested
(Figure 2B). At 24 h, explants infected with MNPE, CDC587, or
MN8 produce 27.7± 2.16-fold, 26.7± 2.28-fold, and 32.3± 2.79-
fold higher levels of IL-8 compared to uninfected explants, respec-
tively. At 48 h post-infection, MNPE-infected explants contain the
lowest amount of IL-8, with an 18.5± 2.70-fold increase, followed
by CDC587-infected explants, which is increased 22.54± 5.16-
fold. MN8-infected explants contain 34.3± 8.52-fold higher IL-8
than uninfected control tissue. By 3 days (72 h) post-infection,
the differences in IL-8 production by MNPE and CDC587 com-
pared to that of uninfected control are less than threefold and
no longer signiﬁcantly different. MN8-infected explants produce
signiﬁcantly higher IL-8, 8.09± 2.21-fold more than uninfected
explants do. The decline in IL-8 detected in MNPE- and CDC587-
infected mucosal tissue over time is likely due to a combination of
FIGURE 2 | Staphylococcus aureus (hla+ and hla−) grow to similar
densities on the mucosal tissue and are proinflammatory.
(A) Quantitation of bacteria growth on tissue. Bacteria were recovered
from unwashed explants infected with MNPE (circles), CDC587 (squares),
or MN8 (triangles). The initial inoculum was ∼1×106 CFU/explant. After
the indicated time, explants were transferred to tubes containing 250μl
PBS and vortex mixed for 4min to recover bacteria. Supernatants were
serially diluted in PBS and plated onTSB agar. Over the ﬁrst 24–48 h, the
bacteria grew logarithmically. There was no change in density from 48 to
72 h. Data are the combined results of two experiments, with n =3 each.
(B) Quantitation of IL-8 from the tissue during the course of infection.
Explants of porcine vaginal mucosa were infected with ∼1×106 CFU of
MNPE, CDC587, or MN8 and incubated at 37˚C for the indicated times.
Explants were then placed in tube containing 250μl PBS and
homogenized for 30 s. Homogenates were clariﬁed by centrifugation and
IL-8 was detected by porcine speciﬁc ELISA. Data were normalized to
uninfected controls at each time point. n =3–4 explants/experiment,
results reﬂect pooled data from two experiments. IL-8 from infected
explants was signiﬁcantly higher than control (uninfected) at 24 and 48 h
post-infection (p<0.05). By 72 h, the amount of IL-8 detected in
homogenates of explants from MNPE or CDC587 was reduced compared
to earlier time points and is no longer statistically signiﬁcant. IL-8 detected
in MN8-infected explant homogenates was reduced compared to earlier
time points, but remains signiﬁcantly higher than controls.
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increased cell death andproteolytic degradation.As time increases,
the proportion of live cells decreases, as does the concentration of
IL-8 detected. These data show that although CDC587 and MN8
are less cytotoxic than MNPE, they are equally proinﬂammatory
to the mucosa.
α-TOXIN IS DETECTED IN THE MUCOSA AFTER INFECTION
The post-inﬂuenza TSS isolate (MNPE) and the mTSS isolates
(CDC587 and MN8) are known to differ in their ability to pro-
duce α-toxin. MNPE,which contains the wild-type gene, expresses
large amounts of α-toxin. CDC587 and MN8, which carry the
pseudogene, is hypothesized to produce less α-toxin. To test this
hypothesis, the accumulation of this toxin in the porcine vaginal
mucosa at 72 h was examined by performing western blotting on
tissue homogenates (Figure 3A). As expected, no toxin is detected
in uninfected tissue, and α-toxin accumulates in the tissue infected
with MNPE. Alpha-toxin accumulates in the tissue infected with
CDC587 to a far lesser extent and appears to be slightly smaller
in size (likely a truncated form of α-toxin). It was a bit surprising
that no α-toxin bands are identiﬁed with S. aureus MN8 because
in a previous exoprotein characterization (Lin et al., 2011), a small
band was identiﬁed. Homogenates from tissue infected with wild-
type MNPE,MNPE hlaKO,wild-type CDC587 or CDC587 hlaKO
were analyzed for α-toxin expression to conﬁrm α-toxin speciﬁcity
FIGURE 3 | α-Toxin is detected in the mucosa after infection. Detection
of α-toxin in explants of porcine vaginal mucosa by western immunoblotting.
At 72 h post-infection with different strains of S. aureus, explants were
transferred to tubes containing 250μl PBS and homogenized for 30 s.
Homogenates were clariﬁed by centrifugation and concentrated ﬁvefold by
ethanol precipitation. Proteins were separated by SDS-PAGE on a 4–20%
gradient gel, transferred and probed with rabbit anti-α-toxin serum. (A)
Based on the position of puriﬁed α-toxin, full-length α-toxin is only detected
in tissue infected with MNPE. Truncated forms were detected in CDC587
and MNPE-infected tissue. No bands were observed in tissue infected with
MN8 or in uninfected tissue. (B) No bands were detected in hlaKO strains.
of the immunoblotting antibody (Figure 3B). As expected, in
the wt MNPE-infected tissue there is an abundance of α-toxin,
but a lack of α-toxin in the homogenate from MNPE hlaKO.
Again, a small amount of slightly (1–2 kDa) truncated α-toxin in
wt CDC587-infected homogenates is observed. This band is not
detected in the CDC587 hlaKO-infected homogenates, demon-
strating a speciﬁc interaction of the anti-sera with α-toxin and
indicates that CDC587 indeed expresses low amounts of α-toxin.
These data demonstrate that α-toxin accumulates in the vaginal
mucosa infected with strains carrying wild-type (hla+) and in
contrast is minimally detected in mutant (hla−) strains.
α-TOXIN PROMOTES S. AUREUS MUCOSAL BIOFILM FORMATION
Rescue experiments with exogenous α-toxin were performed to
determine if α-toxin is both necessary and sufﬁcient for bioﬁlm
formation. As expected with MNPE, large areas of bioﬁlm (green)
over ECM (black) are observed 72 h post-infection (Figure 4B).
In contrast, the epithelium of the MNPE hlaKO-infected explants
contain many live cells (large green ovals) interspersed with dead
cells (large red circles/ovals; Figure 4C). Live bacteria are also
visible (small, green, punctate) as individual cocci or small aggre-
gates. Treatment with 5μg exogenous α-toxin for 72 h resulted
in an increase in epithelial cytotoxicity as evidenced by more
red staining (Figure 4D) compared to untreated, unifected con-
trol (Figure 4A). Treatment with 5μg exogenous α-toxin for 6 h
prior to infection (Figure 4E) or 24 h after infection with the
MNPE hlaKO restored the bioﬁlm phenotype (Figure 4F). These
data demonstrate that α-toxin is both necessary and sufﬁcient for
bioﬁlm formation on a mucosal surface.
α-TOXIN IS NOT REQUIRED FOR S. AUREUS BIOFILM FORMATION ON
PLASTIC
As the vastmajority of bioﬁlm experiments are done using a plastic
substrate and optimal growth media, experiments were performed
to determine if α-toxin plays a critical role in that model. Bioﬁlms
formed in all S. aureus strains tested by 24 h post-inoculation of
96-well tissue culture plates (Figure 5A). No signiﬁcant differences
were observed between strains. This was also the case at 72 h post-
inoculation of the tissue culture plates (Figure 5B). These data
suggest that under optimum conditions,α-toxin is not required to
form bioﬁlm on plastic.
DISCUSSION
Since the 1980s, bioﬁlms have increasingly been recognized as
an important component of human infectious diseases. Bioﬁlm
formation by S. aureus is a multi-stage process involving many
gene products (Gotz, 2002; Heilmann, 2011). The majority of
genes involved in bioﬁlm formation have been identiﬁed using
in vitro culture techniques. The classic in vitro microtiter plate
assay for bioﬁlm formation on abiotic surfaces has been a valuable
tool; however, it does not represent the characteristics of bioﬁlm-
associated infections in vivo andmay have led to an overestimation
of the impact of some molecules in clinical bioﬁlm formation
(Otto, 2008). In vivo experiments are the gold standard in patho-
genesis research, but they are highly labor intensive, expensive, and
subject to regulation. Recognizing these limitations, we developed
an ex vivo porcine mucosal infection model to study microbial col-
onization, infection, and bioﬁlm formation on mucosal surfaces.
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FIGURE 4 | α-Toxin promotes S. aureus biofilm formation. Explants of
normal, healthy porcine vaginal mucosa were infected with ∼1×106 CFU of
live S. aureus strain MNPE or an isogenic α-toxin deletion mutant (MNPE
hlaKO). FilmTracer™LIVE/DEAD stain was used to stain infected porcine
vaginal mucosal epithelium explants. CLSM was used to image explants
3 days post-infection. (A) Mucosa is largely viable (green staining) and intact
(asymmetry). (B) Large masses of bioﬁlm are observed on mucosa infected
with wt MNPE. (C) No bioﬁlm is observed on mucosa infected with MNPE
hlaKO. Live individual cocci and small aggregates (small, bright punctuate, and
irregular shaped green staining) are evident. Many cells of the mucosa remain
alive (green ovals/circles). (D)Treatment of mucosa with 5μg puriﬁed α-toxin
alone for 72 h results in a slight increase in cytotoxicity (red staining). (E)
Treatment of mucosa with 5μg puriﬁed α-toxin for 6 h prior to infection with
MNPE hlaKO restores bioﬁlm formation. (F)Treatment with 5μg α-toxin 24 h
post-infection with MNPE hlaKO restores bioﬁlm formation. Original
magniﬁcation was 60×.
FIGURE 5 | α-Toxin is not required for S. aureus biofilm formation on
plastic. Overnight cultures of various strains of S. aureus were diluted 1:20 in
TSB+0.2% glucose and inoculated into 96-well plates. Cultures were
returned to 37˚C incubator, without shaking, for the indicated times. After
incubation, wells were washed, ﬁxed and stained. O.D. at 570 nm was read
after solubilizing dye with 30% glacial acetic acid. Robust bioﬁlm forms at 24 h
(A) and remains through 72 h (B). No differences were observed between
strains, regardless of α-toxin presence.
The histological and permeability characteristics of porcine vagi-
nal mucosa are very similar to human vaginal mucosa (Squier
et al., 2008).
Staphylococcus aureus initiates diseases at skin and mucosal
surfaces, which are also frequent sites of S. aureus coloniza-
tion. A previously published study identiﬁed differences in the
secreted proteins between two clonally related USA200 TSS S.
aureus isolates,MNPE (hla+) andCDC587 (hla−; Lin et al., 2011).
Stationary phase supernatants from these two isolates differed in
their epithelial cytotoxicity and proinﬂammatory potential, which
was proportional to the amount of α-toxin produced by each
strain. The current study investigates the ability of these strains
to infect vaginal mucosa and form bioﬁlms on the mucosal sur-
face. The cytotoxicity and proinﬂammatory effects of the strains
on vaginal mucosal tissue are also characterized. Using an ex vivo
porcine vaginal mucosa model, a dramatic difference in infection
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phenotypes and mucosal vaginal epithelial cytotoxicity in hla+
strains compared to hla− strains was observed. Speciﬁcally, the
hla+ strain (MNPE) developed a mature bioﬁlm over 3 days and
was signiﬁcantly more cytotoxic over the ﬁrst 24 h. While the
hla− strains CDC587 and MN8 did not form bioﬁlm phenotypes,
despite growing to similar bacterial cell densities and being proin-
ﬂammatory, and were less cytotoxic. This observation is further
supported by our ﬁndings that disruption of the S. aureus α-toxin
gene (MNPE hlaKO) abrogated bioﬁlm formation on mucosal tis-
sue, while the addition of exogenous α-toxin restored the bioﬁlm
phenotype. Our proposed mechanism is that S. aureus α-toxin
contributes to the formation of bioﬁlms on mucosal surfaces
by disrupting the host epithelium, which exposes the ECM for
attachment,provides nutrients for bacterial survival, and facilitates
intercellular bacterial adhesion.
The western blot analysis revealed an abundance of α-toxin in
porcine vaginal mucosa infected with the bioﬁlm-forming MNPE
but none in MNPE hlaKO-infected tissue. This is the ﬁrst study
to examine α-toxin production by MNPE in a bioﬁlm state on
mucosal tissue and these data are consistent with previous ﬁndings
of α-toxin in stationary phase supernatants (Lin et al., 2011). In
this previous study by Lin et al. western blot analysis also revealed
very low amounts of α-toxin secreted by hla− strains of S. aureus
(CDC587 and MN8). Additionally, peptide reads on both sides
of the stop codon at position 113 were observed via mass spec-
trometry. Furthermore, a rabbit red blood cell hemolytic assay
demonstrated that CDC587 and MN8 had more biological activ-
ity (hemolysis) compared to their isogenic α-toxin knockouts.
In the present study, tissue homogenates from CDC587 (hla−)
contained small amounts of α-toxin and the protein appears
to be slightly truncated compared to MNPE and puriﬁed α-
toxin (Figure 3A). Several truncated forms of α-toxin have been
reported in the literature (Kwak et al., 2010; Vecsey-Semjen et al.,
2010). These fragments demonstrate signiﬁcantly lower biolog-
ical activity than the full-length protein, requiring much higher
concentrations and longer incubation times to achieve similar
pathological effects (Kwak et al., 2010). Alpha-toxin is not detected
from tissue homogenates infected with MN8 (hla−) despite of this
strain being very similar to CDC587. This may be a function of
the concentration being below the limit of detection for this assay.
Regardless, this ﬁnding is consistent with a role for α-toxin in
bioﬁlm formation in that MN8 and CDC587 strains failed to form
bioﬁlms over 3 days.
Classically, α-toxin is thought of as a cytolysin. The toxin binds
to host cells, forms a pore and causes leakage of intracellular
contents. A recent study reported that α-toxin not only causes
irreversible pathological changes to the epithelial membrane by
its insertion, but also activates a disintigrin and metallopro-
teinase 10 (ADAM10). This activation results in the shedding of
E-cadherin and severing of homotypic, adherens junction-based
linkages between adjacent cells, which causes disruption at the tis-
sue level (Inoshima et al., 2011). Disruption of the tissue caused
by α-toxinhigh producing strains likely contributes to the pene-
tration of TSST-1 and other superantigens (SAgs) across vaginal
epithelial tissue as has been reported previously (Brosnahan et al.,
2009). Low levels of α-toxin or other secreted exotoxins may
also contribute to SAg accumulation within the tissue. TSST-1
accumulated within the tissue may then serve as a reservoir for
toxin-mediated diseases.
Alpha-toxin has beenproposed to play a role in the formationof
bioﬁlms on abiotic surfaces. Amutant defective in α-toxin failed to
form bioﬁlms in vitro under static conditions in microtiter plate
assays and in ﬂow cell chambers (Caiazza and O’Toole, 2003).
The proposed mechanism for α-toxin promoting bioﬁlm for-
mation was to facilitate bacterial cell-to-cell interactions, which
in turn facilitates macrocolony formation. In contrast to these
ﬁndings, we observed no signiﬁcant differences in the ability of
the USA200 strains (hla+ and hla−) to form bioﬁlms on plastic
microtiter plates. This was not entirely surprising as other fac-
tors are known to be important for bioﬁlm formation on abiotic
surfaces when organisms are grown under optimal conditions,
such as in nutrient-rich media on plastic substrates (Otto, 2008).
Unlike plastic microtiter bioﬁlm assays, the vaginal mucosa is a
comparatively harsh environment, where nutrients are scarce and
bacteria are subject to innate immune defenses, necessitating a
role for α-toxin on the vaginal mucosa in bioﬁlm formation. This
is supported by our current observation of the hla+ strain having
a bioﬁlm phenotype whereas hla− and hlaKO do not.
In contrast to this study, S. aureus strain (UAMS-1), which
carries the α-toxin pseudogene (hla−), causes osteomyelitis, a dis-
ease considered to be bioﬁlm-associated (Smeltzer et al., 1997).
The reasons for this apparent discrepancy are unclear, but per-
haps hla− carrying strains of S. aureus eventually form bioﬁlms
on mucosal surfaces beyond our tested 3 days. Due to limitations
in ex vivo tissue viability, our experiments were conducted for only
3 or 4 days, whereas osteomyelitis takes weeks to develop. Alterna-
tively, α-toxin may not play a role in colonization and subsequent
infection of bone, especially since the bioﬁlm substrate of bone
is very different from the bioﬁlm substrate of epithelial tissue.
Together, in vitro and in vivo studies suggest that regulation of
α-toxin by quorum sensing or by the presence of a pseudogene
(hla−) and the role of α-toxin in S. aureus bioﬁlm formation on
host tissues is complicated and not completely understood. This
underscores the need for anatomical site speciﬁcity for accurate
and clinically predictive models of staphylococcal diseases.
Although the ex vivo porcine mucosal tissue infection model
is similar to human vaginal mucosa and was developed to more
closely mimic in vivo conditions, the vaginal mucosa was not sub-
jected to vaginal secretions or menstrual ﬂuids, which may cause
the outermucosa to slough and/or impede the ability of the organ-
isms to infect and/or produce exotoxins such as α-toxin. Further,
due to the lack of a blood supply, there is no neutrophil inﬂux,
which is critical for controlling early bacterial growth. Taking these
limitations into consideration, we still believe that our model is an
improvement over in vitro abiotic bioﬁlm models.
Our bioﬁlm model is of much shorter experimental dura-
tion than some existing models due to tissue viability limitations.
However, menstrual TSS commonly occurs within 2–3 days post
initiation of menses,which is within the timeframe of our study. In
addition, this study only describes one hla+USA200 MSSA TSST-
1+ isolate compared to its isogenic hlaKOand two hla− containing
organisms. Therefore, whether all hla+ TSST-1+ S. aureus isolates
would form a bioﬁlm over 72 h on mucosal tissue is unknown.
However,we have determined that a methicillin-resistant S. aureus
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α-toxinhigh, TSST-1+ isolate (I6) is also highly toxic to vagi-
nal mucosal tissue and forms a bioﬁlm by day 3 post-infection
(unpublished data).
The role of α-toxin in S. aureus mucosal bioﬁlm formation
in vivo has not been characterized. However, this cytolysin is
known toplay a role in thepathogenesis of S. aureus,basedon stud-
ies of mutants lacking α-toxin (Bramley et al., 1989). For example,
in a murine model of peritonitis, α-toxin was shown to be of criti-
cal importance when only mice injected with wild-type hla+ died
(Patel et al., 1987).More recently,α-toxin has been reported to play
a signiﬁcant role in lung tissue damage during murine staphylo-
coccal pneumonia (Bubeck Wardenburg and Schneewind, 2008).
Researchers determined that virulence correlated with expression
levels of α-toxin and further demonstrated that vaccination with a
non-pore formingα-toxin (hlaH35L) protectedmice from S. aureus
pneumonia (Kennedy et al., 2010). Vaccines targeting α-toxin may
prevent S. aureus vaginal mucosal bioﬁlm formation, but not S.
aureus infection or toxin (SAg)-mediated diseases. This is because
α-toxin-deﬁcient strains (MN8 and CDC587) were not avirulent,
but rather caused a different type of infection.
We have termed these non-bioﬁlm-forming isolates HDPV
because they grow to a similar density on tissue, are
proinﬂammatory to the tissue and can secrete other virulence
factors, such as SAgs, which can lead to toxin-mediated diseases.
These data also suggest that α-toxin may be a potent thera-
peutic target for some diseases. More speciﬁcally, neutralizing
α-toxin may reduce the organism’s ability to form bioﬁlms, ren-
dering it more sensitive to antimicrobial agents and host immune
responses. Ultimately, ex vivo tissue models, like the one described,
and follow-up in vivo studies are needed to determine the bacterial
and host factors which contribute to S. aureus colonization, infec-
tion and bioﬁlm formation in humans so optimal therapeutics to
prevent and treat staphylococcal infections can be developed.
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